Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 62   

Articles published

NIPT 9.25 +0.38 (4.23%)
price chart
Premaitha Health PLC Premaitha Health signs Investment Agreement with Thermo ...
Premaitha's CE-marked, non-invasive prenatal screening (NIPT) product, the IONA� test, runs on Thermo Fisher's two sequencing instruments, the Ion Proton and Ion Chef.
Premaitha Health PLC 131.7% Potential Upside Indicated by finnCap
Premaitha Health PLC using EPIC/TICKER code LON:NIPT had its stock rating noted as 'Initiates/Starts' with the recommendation being set at 'CORPORATE' this morning by analysts at finnCap.
Premaitha Health Plc (LON:NIPT) Receives Corporate Rating From FinnCap Analysts  Risers & Fallers
PEG Ratio (5 yr expected):
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom.
Recent Research Analysts' Ratings Updates for Premaitha Health PLC (NIPT)
3/29/2016 - Premaitha Health PLC had its “buy” rating reaffirmed by analysts at Panmure Gordon. They now have a GBX 24 ($0.34) price target on the stock.
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company But Struggles To  London South East
Related articles »  
Premaitha Health PLC bags tenth customer
Premaitha Health PLC (LON:NIPT) has landed a tenth customer for its IONA diagnostic, Europe's first CE-marked non-invasive DNA-based pre-natal test for Down's Syndrome.
Premaitha Health Plc (LON:NIPT) Receives 'Corporate' Rating From FinnCap
On Monday finnCap reiterated its rating on shares of Premaitha Health Plc as 'Corporate' issuing a recommended target price of 20 potentially meaning there is an increase of 121.01% from Premaitha Health Plc's share price of 9.05. Premaitha Health Plc ...
Are Analysts Bearish Premaitha Health PLC (LON:NIPT) After Last Week?
Out of 2 analysts covering Premaitha Health Plc (LON:NIPT), 1 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive.
Premaitha Health (LON:NIPT) Broker Roundup  Fiscal Standard
Outstanding Analyst Ratings For Premaitha Health (LON:NIPT)
Premaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques.
Premaitha Health (LON:NIPT) Issued With 'Corporate' Rating At FinnCap
Premaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques.
Premaitha Health PLC (NIPT) Coverage Initiated at FinnCap  Let Me Know About This